In general, this MR investigation revealed that within European subjects, genetically‐predicted NAFLD, cALT levels, and cirrhosis exhibited positive relationships with liver and intrahepatic bile ducts cancer. This evidence concerns the gene CETN2 and metabolic dysfunction-associated steatotic liver disease.